Answers are grounded in this paper and cite their sources.
The cell-surface associated molecule Cripto is overexpressed in a wide range of epithelial cancers, yet little is known about potential mechanisms by which Cripto expression might enhance tumorigenesis. A new study reveals that binding of Cripto to the TGF-beta ligand Activin B can block Activin B-mediated suppression of cell proliferation. Furthermore, this study also demonstrates that antibody blockade of Cripto function may prove useful in the inhibition of tumorigenesis.
No takes yet. Share an insight, caveat, or question.
Michael M. Shen (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: